Montreal Cognitive Assessment
Montreal Cognitive Assessment Scale · Also known as: MoCA, MoCA Test, Montreal Cognitive Assessment Test
The Montreal Cognitive Assessment (MoCA) is a brief 10-minute cognitive screening test designed to detect mild cognitive impairment (MCI) in older adults. Developed by Nasreddine and colleagues in 2005 at McGill University, MoCA is more sensitive to cognitive impairment than the Mini-Cog or MMSE, particularly for detecting early Alzheimer's disease and non-Alzheimer dementias, making it widely used in primary care, neurology, and geriatric medicine.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
MoCA is the gold standard brief cognitive screening tool in primary care, neurology, geriatrics, and memory clinics for detecting MCI and early dementia. Use at baseline in older adults with cognitive concerns, during routine health maintenance screening in populations at risk (age >55, family history), and as a follow-up measure to track cognitive decline. MoCA is also valuable in research screening for cognitive impairment in trials and cohort studies.
Strengths & limitations
- Superior sensitivity to MMSE for detecting mild cognitive impairment and early dementia (90% vs. 45% sensitivity in MCI populations).
- Comprehensive assessment of eight cognitive domains including executive function, which is often spared in MMSE but impaired in Alzheimer's and non-Alzheimer dementias.
- Brief 10-minute administration feasible in busy clinic settings and ideal for screening large populations.
- Available in 35+ languages with validated international versions; strong psychometric properties across diverse populations and healthcare systems.
- Requires formal training and administration by educated clinician; not suitable as self-administered patient-completed screener.
- Ceiling effects in highly educated individuals may reduce sensitivity; floor effects in advanced dementia reduce discrimination at the severe end.
- Performance influenced by education, language, and cultural factors; adjusted cutoffs needed for low-education populations.
- Does not diagnose dementia definitively; abnormal MoCA score requires further neuropsychological testing and medical workup to establish diagnosis.
Frequently asked
What is the difference between MoCA and MMSE?
MMSE focuses on memory and orientation with limited assessment of executive function (10-minute, 30 items). MoCA includes more executive function and visuospatial items (10 minutes, 30 items) and has higher sensitivity for MCI (90% vs. 45%). MMSE is easier to administer; MoCA requires more clinician training. Use MoCA for cognitive impairment detection; MMSE for quick dementia severity assessment in known dementia.
What does a MoCA score of 24 mean?
A score of 24 falls in the mild cognitive impairment range (18–25) and suggests cognitive decline beyond normal aging. This score warrants further neuropsychological testing, neuroimaging (MRI to rule out stroke or atrophy), and medical workup (vitamin B12, thyroid function) to identify reversible causes and establish dementia diagnosis.
Do I need to add 1 point for education adjustment?
Yes, add 1 point if the patient has fewer than 12 years of education. Without this adjustment, normal-cognition patients with low education may score below 26 and be falsely classified as cognitively impaired. Document whether education adjustment was applied in the patient record.
How often should I repeat MoCA in patients with normal scores?
In cognitively normal older adults without cognitive concerns, annual MoCA screening is sufficient. In patients with MCI or baseline cognitive decline, repeat every 6–12 months to track progression. More frequent testing (monthly) is not recommended without clinical indication (e.g., acute change).
Sources
- Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., ... & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. DOI: 10.1111/j.1532-5415.2005.53221.x ↗
- Vlachos, G. S., & Scarmeas, N. (2019). Objectives, design and main findings of the REMEDIO project: a longitudinal study on the role of Mediterranean diet on cognitive decline. Journal of Alzheimer's Disease, 70(Suppl 1), S5–S22. link ↗
How to cite this page
ScholarGate. (2026, June 3). Montreal Cognitive Assessment Scale. ScholarGate. https://scholargate.app/en/rehabilitation/moca
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Clinical Dementia RatingRehabilitation↔ compare